RESUMEN
AIMS/HYPOTHESIS: Improved glucose control in type 2 diabetes is known to reduce the risk of microvascular events. There is, however, continuing uncertainty about its impact on macrovascular disease. The aim of these analyses was to generate more precise estimates of the effects of more-intensive, compared with less-intensive, glucose control on the risk of major cardiovascular events amongst patients with type 2 diabetes. METHODS: A prospectively planned group-level meta-analysis in which characteristics of trials to be included, outcomes of interest, analyses and subgroup definitions were all pre-specified. RESULTS: A total of 27,049 participants and 2,370 major vascular events contributed to the meta-analyses. Allocation to more-intensive, compared with less-intensive, glucose control reduced the risk of major cardiovascular events by 9% (HR 0.91, 95% CI 0.84-0.99), primarily because of a 15% reduced risk of myocardial infarction (HR 0.85, 95% CI 0.76-0.94). Mortality was not decreased, with non-significant HRs of 1.04 for all-cause mortality (95% CI 0.90-1.20) and 1.10 for cardiovascular death (95% CI 0.84-1.42). Intensively treated participants had significantly more major hypoglycaemic events (HR 2.48, 95% CI 1.91-3.21). Exploratory subgroup analyses suggested the possibility of a differential effect for major cardiovascular events in participants with and without macrovascular disease (HR 1.00, 95% CI 0.89-1.13, vs HR 0.84, 95% CI 0.74-0.94, respectively; interaction p = 0.04). CONCLUSIONS/INTERPRETATION: Targeting more-intensive glucose lowering modestly reduced major macrovascular events and increased major hypoglycaemia over 4.4 years in persons with type 2 diabetes. The analyses suggest that glucose-lowering regimens should be tailored to the individual.
Asunto(s)
Glucemia/análisis , Diabetes Mellitus Tipo 2/fisiopatología , Angiopatías Diabéticas/prevención & control , Glucemia/metabolismo , Presión Sanguínea , Colesterol/sangre , Ensayos Clínicos como Asunto , Diabetes Mellitus Tipo 2/sangre , Ayuno , Estudios de Seguimiento , Hemoglobina Glucada/análisis , Homeostasis , Humanos , Cooperación del Paciente , Selección de Paciente , Conducta de Reducción del Riesgo , Resultado del TratamientoRESUMEN
Few large prospective studies of adverse reactions after bacille Calmette-Guérin (BCG) vaccination are available. In a prospective national study of such adverse reactions among 918 subjects (aged 1 day to 54 years) over a 14-month period, 45 vaccinees (5%) reported 53 adverse reactions (23 injection-site abscesses, 14 severe local reactions, 10 cases of lymphadenitis, and 6 other reactions). Only 1% of vaccinees required medical attention. Reactions, particularly lymphadenitis, were significantly less common in infants <6 months old (but not in subjects aged > or =6 months) vaccinated by trained (vs. untrained) providers (relative risk [RR], 0.24; 95% confidence interval [CI], 0.09-0.68). Injection-site abscesses (RR, 2.96; 95% CI, 1.11-7.90) and severe local reactions (RR, 4.93; 95% CI, 1.11-21.90) were significantly more common in older vaccinees. Local reactions were more frequently reported by adult females than by adult males (RR, 7.18; 95% CI, 1.59-32.45). Adverse reactions were not significantly associated with any currently available vaccine batch, previous receipt of BCG vaccine, or concomitant administration of other vaccines.
Asunto(s)
Vacuna BCG/efectos adversos , Adolescente , Adulto , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Estudios ProspectivosRESUMEN
To evaluate the impact of the 1998 Australian Measles Control Campaign on immunity to measles and rubella, 4400 opportunistically-collected sera, submitted to diagnostic laboratories across Australia from subjects aged 1-49 years, and 3000 from subjects aged 1-18 years, were tested before and after the campaign, respectively. The proportion of individuals aged 1-18 years who were immune to measles rose from 85% before, to 90% after, the campaign (P < 0.001). The greatest increase was in preschool (7%, P < 0.001) and primary school (10%, P < 0.001) children, who were actively targeted by the campaign. Rubella immunity in 1-18 year-olds rose from 83% to 91% (P < 0.0001), again with significant increases in preschool (4%, P = 0.002) and primary school (16%, P < 0.001) children. 94% of individuals aged 19-49 years were immune to rubella. These serosurveys confirm other evidence of the effectiveness of the Australian Measles Control Campaign and demonstrate the value of serosurveillance using opportunistically collected sera.
Asunto(s)
Vacuna Antisarampión , Sarampión/inmunología , Vigilancia de la Población , Rubéola (Sarampión Alemán)/inmunología , Adolescente , Adulto , Distribución por Edad , Anticuerpos Antivirales/aislamiento & purificación , Australia , Niño , Preescolar , Femenino , Humanos , Programas de Inmunización , Lactante , Masculino , Sarampión/sangre , Sarampión/prevención & control , Rubéola (Sarampión Alemán)/sangre , Rubéola (Sarampión Alemán)/prevención & control , Estudios SeroepidemiológicosRESUMEN
The 1998 Australian Measles Control Campaign had as its aim improved immunization coverage among children aged 1-12 years and, in the longer term, prevention of measles epidemics. The campaign included mass school-based measles-mumps-rubella vaccination of children aged 5-12 years and a catch-up programme for preschool children. More than 1.33 million children aged 5-12 years were vaccinated at school: serological monitoring showed that 94% of such children were protected after the campaign, whereas only 84% had been protected previously. Among preschool children aged 1-3.5 years the corresponding levels of protection were 89% and 82%. During the six months following the campaign there was a marked reduction in the number of measles cases among children in targeted age groups.
Asunto(s)
Programas de Inmunización , Sarampión/prevención & control , Adolescente , Adulto , Australia/epidemiología , Niño , Preescolar , Notificación de Enfermedades , Humanos , Lactante , Sarampión/epidemiología , Vacuna contra el Sarampión-Parotiditis-Rubéola/administración & dosificación , Evaluación de Programas y Proyectos de SaludRESUMEN
A single blinded randomized controlled trial to compare the reactogenicity and immunogenicity of adult formulated dTpa and monovalent pa vaccines with a licensed Td vaccine. Five hundred and forty-eight healthy adults aged 19-70 years received a single injection of dTpa or separate injections of pa or Td (with the alternate vaccine 1 month later). Local and systemic reactions were monitored for 15 days after each vaccination. Serum antibody levels were measured immediately prior to and 1 month after vaccination. Antibody levels were measured 12 months after vaccination in 100 subjects. There was no difference in the total frequency of symptoms and signs between subjects receiving any of the three vaccines. There was a significantly lower incidence of local reactions following pa (60%) than dTpa (80%, P=0.002) or Td (93%, P=0.0008). The incidence of clinically significant (Grade 2 or 3) swelling (> or =20 mm) was higher for Td (20%, P=0.002) than for dTpa (11%) or for pa (2%), however, there were no other significant differences in the incidence of Grade 2 or 3 reactions between the vaccines. A high anti-pertussis seroconversion rate (>97%) against all the studied pertussis antigens was seen 1 month after vaccination with dTpa and pa. A total of 96 and 99% of subjects receiving dTpa and Td, respectively, had anti-diphtheria titres > or =0.01 IU/ml, and all but one subject had anti-tetanus titres > or =0.1 IU/ml after 1 month. Twelve months after vaccination the majority (90-100%) of the subjects were still seropositive for each antigen and although GMTs had decreased they were substantially higher than pre-vaccination levels. The dTpa vaccine was well tolerated and capable of eliciting an immune response against all the antigens in a broad spectrum of the adult population and could potentially replace Td for routine boosters in adults.
Asunto(s)
Vacuna contra Difteria y Tétanos/inmunología , Vacunas contra Difteria, Tétanos y Tos Ferina Acelular/inmunología , Vacuna contra la Tos Ferina/inmunología , Factores de Virulencia de Bordetella , Adhesinas Bacterianas/inmunología , Adulto , Anciano , Anticuerpos Antibacterianos/sangre , Antígenos Bacterianos/inmunología , Proteínas de la Membrana Bacteriana Externa/inmunología , Vacuna contra Difteria y Tétanos/efectos adversos , Vacunas contra Difteria, Tétanos y Tos Ferina Acelular/efectos adversos , Femenino , Estudios de Seguimiento , Hemaglutininas/inmunología , Humanos , Masculino , Persona de Mediana Edad , Vacuna contra la Tos Ferina/efectos adversos , Toxoides/inmunologíaRESUMEN
Although the literature affirms the superiority of block resection over local excision for the surgical treatment of early squamous cell carcinoma of the anterior floor of the mouth, the best method of block resection is not certain. Two methods are in widespread use; a horizontal procedure (HB) and a vertical procedure (VB). This retrospective study compares these two procedures according to outcome in separate series of patients treated between 1970 and 1984. Patients were followed for a minimum of 3 years with an average follow-up of 6 years. Twenty-five patients underwent HB while 27 underwent VB. Control at the primary site was 100% for HB and 74% for VB. Neck metastasis and distant metastasis occurred with equal frequency. Determinate survivals at 3 and 5 years were 96% and 91% for the HB group and 93% and 65% for the VB group. Local recurrence correlated with tumor growth posteriorally toward the ventrum of the tongue, suggesting an explanation for the difference in outcome between the two procedures. We conclude that the HB procedure is the preferable surgical procedure for stage I and II disease.
Asunto(s)
Carcinoma de Células Escamosas/cirugía , Suelo de la Boca/cirugía , Neoplasias de la Boca/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Escamosas/mortalidad , Carcinoma de Células Escamosas/secundario , Femenino , Neoplasias de Cabeza y Cuello/secundario , Humanos , Metástasis Linfática , Masculino , Métodos , Persona de Mediana Edad , Neoplasias de la Boca/mortalidad , Recurrencia Local de Neoplasia , Neoplasias Primarias Múltiples , Estudios Retrospectivos , Factores de RiesgoRESUMEN
A technique of antro-ethmosphenoidectomy has evolved over the last 50 years to provide a thorough, yet safe method of treating chronic, recurrent advanced pansinusitis. The trans-antral approach to the ethmoid labyrinth and sphenoid sinuses was first described before the turn of this century. A brief chronological history is reviewed in order to understand the development and then the abandonment of this surgery for over twenty years. This was followed by a renewed interest in the procedure conforming to the modern concepts of nasal physiology and rhinologic surgery. Because of the wide visual surgical exposure, the antro-ethmosphenoidectomy approach is most ideally adapted to pituitary, skull base and orbital decompression procedures.
Asunto(s)
Senos Etmoidales/cirugía , Sinusitis/cirugía , Seno Esfenoidal/cirugía , Historia del Siglo XIX , Historia del Siglo XX , Humanos , Otolaringología/historia , Estados UnidosRESUMEN
The authors describe the technique of a transantral transsphenoidal approach to the sella turcica. The advantages and potential complications are discussed. This procedure may also be applicable when dealing with tumors of the skull base and orbits.